£795.00

The 2023-2028 World Outlook for Cardiovascular Genetic Testing

Subjects

Price data last checked 136 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 595 days • 595 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 595 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (595 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 595 days

Description

This study covers the world outlook for cardiovascular genetic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of cardiovascular genetic testing as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Admera Health, deCODE genetics, F. Hoffmann-La Roche, Genomic Health, HTG Molecular Diagnostics, ICON, IntegraGen., Laboratory Corporation of America Luminex Corporation, Myriad Genetics, Natera, Pacific Biosciences, Pathway Genomics, Qiagen, and Siemens Healthcare. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B09Y9FRBDJ
Category: Books > Subjects
Domain: Amazon UK
Release Date: 10 May 2022
Listed Since: 02 May 2022

The 2023-2028 World Outlook for Cardiovascular Genetic Testing

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023 Report on Molecular Carrier Screening Tests: World Market Segmentation by City

The 2023 Report on DNA Testing: World Market Segmentation by City

The 2027-2032 World Outlook for Biotechnology Molecular Diagnostics

Genetics and Genomics in Medicine

Genetics and Genomics in Medicine

Academic Press Advances in Genetics: Volume 108 - Book

Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Perinatal and Reproductive Genetics

The 2027-2032 World Outlook for Biotechnology Instrumentations

Gene Mapping: Using Law and Ethics as Guides

The 2027-2032 World Outlook for Biotechnology Epigenetics

Springer Responsible Genetics: Moral Responsibility in Research

Clinical Molecular Medicine: Principles and Practice

Advances in Genetics (Volume 107)

Advances in Genetics: Volume 104

Computational Genetics: Advanced Data Analysis Programming with R and Bioconductor (Genesis Protocol: Next Generation Technology for Biological and Life Sciences)

Managing Health in the Genomic Era: A Guide to Family Health History and Disease Risk

Molecular Diagnostics

Genomics In Asia: A Clash Of Bioethical Interests - Routledge

Introduction to Genetics: A Molecular Approach

The 2027-2032 World Outlook for Biotechnology Immunoassay Instrumentation Systems

Human Population Genetic Research in Developing Countries: The Issue of Group Protection (Biomedical Law and Ethics Library)

Essentials of Medical Genetics for Health Professionals

Time-Resolved Mass Spectrometry: From Concept to Applications

A Primer of Human Genetics